Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615219-17-000007
Filing Date
2017-01-20
Accepted
2017-01-20 09:02:56
Documents
1
Period of Report
2017-01-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_148492096383173.html 4  
1 FORM 4 wf-form4_148492096383173.xml 4 3842
  Complete submission text file 0001615219-17-000007.txt   5234
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FLEX PHARMA, INC. 800 BOYLSTON STREET, 24TH FLOOR BOSTON MA 02199
Business Address
Hadfield Robert (Reporting) CIK: 0001630687 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36812 | Film No.: 17537605